$3.45
-0.04-1.15%
At close: -
$3.48
0.030.87%
After Hours: 9:29 AM EDT
Comments
Loading...
MaxCyte (NASDAQ:MXCT) Stock Quotes, Forecast and News Summary
MaxCyte Stock (NASDAQ: MXCT) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy MaxCyte (MXCT) stock?
You can purchase shares of MaxCyte (NASDAQ:MXCT) through any online brokerage.
Who are MaxCyte (MXCT) competitors?
Other companies in MaxCyte’s space includes: Harvard Bioscience (NASDAQ:HBIO), Codexis (NASDAQ:CDXS), BioLife Solns (NASDAQ:BLFS), Lifecore Biomedical (NASDAQ:LFCR) and Quanterix (NASDAQ:QTRX).
What is the forecast, or price target, for MaxCyte (MXCT) stock?
MaxCyte has a consensus price target of $8.67.
What is the current price for MaxCyte (MXCT)?
The stock price for MaxCyte (NASDAQ: MXCT) is $3.48 last updated November 21, 2024 at 9:29 AM EST.
Does MaxCyte (MXCT) pay a dividend?
There are no upcoming dividends for MaxCyte.
When is MaxCyte (NASDAQ:MXCT) reporting earnings?
MaxCyte’s Q3 earnings are confirmed for Wednesday, November 6, 2024.
Is MaxCyte (MXCT) going to split?
There is no upcoming split for MaxCyte.
What sector and industry does MaxCyte (MXCT) operate in?
MaxCyte is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.